Category: australia retractions

NEJM pulls letter by heart researcher who faked patient records

Screen Shot 2015-11-30 at 10.08.23 AMA heart researcher who fabricated patient records has notched retraction number six — this time, for a letter in the New England Journal of Medicine. She has two more retractions forthcoming.

The retraction comes at the request of Anna Ahimastos’s co-authors, following an investigation into her work by her former workplace, the Baker IDI Heart and Diabetes Institute. The investigation was not able to verify the data referenced in the letter, which includes a citation for a recently retracted JAMA paper.

The retraction note is similar to others for Ahimastos’s papers:

Continue reading NEJM pulls letter by heart researcher who faked patient records

Investigation finds data issues polluted air quality paper

1-s2.0-S0013935113X0009X-cov150hAn investigation at the Queensland University of Technology in Australia has found that a paper on air pollution and human health contains a host of issues with the data and its analysis. The paper has been retracted with a very detailed note from Environmental Research.

The issues with the paper include an “incorrect analysis of the data,” and its failure to properly cite multiple papers and one researcher’s contributions. Ultimately, according to the retraction note, the investigation found that the “conclusions of the paper are flawed.”

“Submicrometer particles and their effects on the association between air temperature and mortality in Brisbane, Australia” has been cited three times, according to Thomson Scientific’s Web of Knowledge.

The retraction note is very, very detailed. It outlines the problems with the paper:

Continue reading Investigation finds data issues polluted air quality paper

Author withdraws entire issue after overseeing his own peer review

home_cover-31The editor and author of most of the papers in a special issue of a math journal told us he is withdrawing the entire issue following revelations that he had coordinated the peer-review process.

The articles, published online earlier this year, recently received an expression of concern after the journal realized the guest editor David Gao, at the Federation University Australia, had coordinated the peer-review process. This was a major no-no, since Gao was also an author of 11 of the 13 papers. Mathematics and Mechanics of Solids slated the articles to be peer reviewed again, by reviewers not chosen by Gao.

Gao told us what happened next, from his perspective — he changed his mind about publishing the papers in MMS:

Continue reading Author withdraws entire issue after overseeing his own peer review

JAMA retracts second paper by heart researcher

Screen-Shot-2015-10-27-at-10.53.53-AMA heart researcher who fabricated trial participants has notched a second JAMA retraction. The retraction comes at the request of her co-authors, after an investigation by her former employer wasn’t able to confirm that this study was valid.

In September, we learned that Anna Ahimastos, who used to work at Baker IDI Heart and Diabetes Institute in Melbourne, Australia, had “fabricated [records] for trial participants that did not exist” in a JAMA trial for a blood pressure drug, according to principal investigator Bronwyn Kingwell.  That trial was retracted, along with a sub analysis.

An investigation by the institute found problems or sufficient doubt in several more publications. This second JAMA retraction is number 5 for Ahimastos, of 8 total expected.

The paper, “Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial” Continue reading JAMA retracts second paper by heart researcher

Heart researcher who faked patient data gets third retraction

Screen Shot 2015-11-06 at 6.38.09 PMA heart researcher has notched her third retraction, a small 2006 trial in Annals of Internal Medicine which seemed to show that a blood pressure drug could help people with artery disease walk further with less pain.

Earlier this year, Anna Ahimastos, formerly a researcher at Baker IDI Heart and Diabetes Institute in Melbourne, lost a larger clinical trial in JAMA and a subanalysis in Circulation Research after it was discovered she’d fabricated patient records. As principle investigator Bronwyn Kingwell told us in September:

Specifically, records were fabricated for trial participants that did not exist.

Now, following an investigation by the institute, her co-authors are proactively retracting papers, with more to come. The Annals of Internal Medicine paper, “Ramipril Markedly Improves Walking Ability in Patients With Peripheral Arterial Disease,” is being pulled due to an “inability to adequately validate primary data sources.” According to the note, Ahimastos “maintains the integrity of the data and validity of reported results:”

Continue reading Heart researcher who faked patient data gets third retraction

Author’s coordination of peer review flags 13 math papers

home_cover (3)Thirteen papers in Mathematics and Mechanics of Solids now have an expression of concern, after it came to light that an author on most of the papers coordinated the peer-review process.

David Y. Gao, a well-known and prolific mathematician at the Federation University Australia, is the author of 11 of the papers, and also the guest editor of the special issue in which they were set to appear. The papers were published online earlier this year.

A spokesperson for SAGE, which publishes the journal, confirmed that the publisher decided to re-review the papers after learning about Gao’s role in the peer-review process:

Continue reading Author’s coordination of peer review flags 13 math papers

“Irresolvable authorship dispute” leads to retraction of tropical disease paper

Microbiology AustraliaA paper on schistosomiasis, a tropical disease spread by parasitic worms that live in freshwater snails, has been pulled because of an “irresolvable authorship dispute.”

Microbiology Australia published the retraction earlier this month in an agreement with the editors and the authors. Unfortunately, the notice doesn’t provide many details and that’s pretty much all we know.

Here’s the notice in full:

Continue reading “Irresolvable authorship dispute” leads to retraction of tropical disease paper

Violent songs can lead to spicy food, and other lessons we learned from corrected graphic

S00221031

A correction to a 2011 paper doesn’t change its main conclusion: Hearing song lyrics about violence — “let the bodies hit the floor,” for example — can prompt aggressive behavior, even more so than violent imagery in music videos.

The correction follows an investigation by Macquarie University that found errors in data analysis to be an “honest mistake.”

During the study — “The effect of auditory versus visual violent media exposure on aggressive behaviour: The role of song lyrics, video clips and musical tone,” published in the Journal of Experimental Social Psychology — the authors measured the effect of violent songs or imagery using the “hot sauce paradigm.” In this model, researchers estimate people’s level of aggression by how much hot sauce they give another person to eat. The study found that, indeed, people who are exposed to violence — particularly, lyrics —  give more hot sauce to their neighbors. It has been cited 6 times, according to Thomson Scientific’s Web of Knowledge.

One aspect of the paper prompted a tweet from a Dutch journalist: Continue reading Violent songs can lead to spicy food, and other lessons we learned from corrected graphic

“Fabricated results” retract JAMA clinical trial, plus a sub-analysis of the data

Screen Shot 2015-09-14 at 11.00.11 AMA JAMA clinical trial that suggested a blood pressure drug could help patients increase their physical fitness, and a sub-analysis of those data, have been retracted after “an admission of fabricated results” by the first author on both papers.

The three-year clinical trial was published in JAMA in 2013.  It was retracted this morning.

The trial found ramipril helped patients with artery disease walk longer and with less pain, according to the abstract:

Among patients with intermittent claudication, 24-week treatment with ramipril resulted in significant increases in pain-free and maximum treadmill walking times compared with placebo. This was associated with a significant increase in the physical functioning component of the SF-36 score.

The retraction note explains how the fabricated data came to light: 

Continue reading “Fabricated results” retract JAMA clinical trial, plus a sub-analysis of the data

“Our manuscript unintentionally failed to meet academic and publication standards”

homeHeaderTitleImage_en_US

Authors of a 2014 review paper about the use of “as needed” medications by people with mental health diagnoses are retracting it, but we’re scratching our heads as to why.

The retraction appears in “The experiences of mental health professionals’ and patients’ use of pro re nata (PRN) medication in acute adult mental health care settings: a systematic review protocol of qualitative evidence,” published by The JBI Database of Systematic Reviews and Implementation Reports.

From the abstract of the paper:

Pro re nata is a Latin phrase meaning “for an unforseen need or contingency”…The authors of the systematic review found that although the practice of using “as required” medication is common there is no good evidence of whether this is the best way of helping people to be less agitated when compared to being given a regular dose of medication.

We’re not entirely sure what went wrong here. This is the full contents of the note:

Continue reading “Our manuscript unintentionally failed to meet academic and publication standards”